tiprankstipranks
Trending News
More News >
Arkema SA (UK) (FR:AKE)
:AKE

Arkema (AKE) AI Stock Analysis

Compare
26 Followers

Top Page

FR

Arkema

(LSE:AKE)

Rating:67Neutral
Price Target:
€67.00
▲(1.52%Upside)
Arkema's overall stock score reflects stable financial performance with notable challenges in profitability and cash flow. Technical indicators are neutral with potential bearish trends, while valuation is attractive with a high dividend yield. The absence of earnings call insights leaves some information gap in assessing future prospects.
Positive Factors
Earnings
The earnings trend at Performance Additives is up (+15% y/y in FY-24) and had a good start to 2025.
Price Target
Upside to Price Target (%) 25.8.
Negative Factors
Debt
Net debt increased y/y to €3.24bn (FY-23: €2.9bn) with net debt/EBITDA at 2.1x.
Demand
The company highlighted weak demand at the start of the year and ongoing uncertainties in acrylics.
Industry Performance
Lowering estimates on softer demand trends and weaker industry performance.

Arkema (AKE) vs. iShares MSCI France ETF (EWQ)

Arkema Business Overview & Revenue Model

Company DescriptionArkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It provides adhesive solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. The company also offers advanced materials consisting of specialty polyamides and polyvinylidene fluoride; and performance additives, such as specialty surfactants and molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide for use in automotive and transportation, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition, and water treatment sectors. In addition, it provides coating solutions comprising EU/US acrylics and coating resins; sartomer photocure resins and coatex rheology additives; decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbents, water treatment and oil and gas extraction, and 3D printing and electronics industries. Further, the company offers fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.
How the Company Makes MoneyArkema makes money primarily through the sale of its specialty chemicals and advanced materials across its three main business segments. The High Performance Materials segment generates revenue through products like adhesives, technical polymers, and performance additives, which are used in high-growth industries such as automotive and electronics. The Industrial Specialties segment includes fluorogases, PMMA (acrylic glass), and hydrogen peroxide, contributing to revenue through applications in refrigeration, construction, and healthcare sectors. The Coating Solutions segment covers products like coating resins and additives, serving the paints, coatings, and adhesives markets. Arkema's earnings are further supported by strategic partnerships, research and development investments, and its focus on sustainable and innovative solutions that meet evolving customer demands.

Arkema Financial Statement Overview

Summary
Arkema's financial performance shows stability in revenue but declining profitability and cash flow generation. The balance sheet remains solid with a strong equity base, though increased leverage and reduced return on equity pose challenges. Improving cost efficiency and cash flow management will be crucial for future growth.
Income Statement
72
Positive
Arkema's income statement reflects moderate stability with a slight revenue growth of 0.31% in 2024. The gross profit margin is stable at approximately 20.3% for 2024, however, the net profit margin decreased to 3.71%, indicating reduced profitability. The EBIT and EBITDA margins have slightly decreased, suggesting a need for cost management improvements.
Balance Sheet
68
Positive
The balance sheet exhibits a healthy equity ratio of 49.5%, implying a strong equity base. The debt-to-equity ratio increased to 0.60, indicating increased leverage. Return on equity declined to 4.70%, showing reduced efficiency in generating returns from equity.
Cash Flow
65
Positive
Cash flow analysis reveals a significant decline in free cash flow by 43.24% in 2024, raising concerns about cash generation. The operating cash flow to net income ratio is robust at 3.17, but the free cash flow to net income ratio dropped to 1.00, reflecting less cash available for expansion or shareholder returns.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue9.54B9.51B11.55B9.52B7.88B
Gross Profit1.94B1.96B2.58B2.14B1.55B
EBITDA1.31B1.33B1.82B2.27B1.19B
Net Income354.00M402.00M965.00M1.31B332.00M
Balance Sheet
Total Assets15.21B14.52B13.51B12.30B10.71B
Cash, Cash Equivalents and Short-Term Investments2.01B2.04B1.59B2.29B1.63B
Total Debt4.55B4.28B3.26B2.76B2.80B
Total Liabilities7.45B7.06B6.17B5.95B5.48B
Stockholders Equity7.53B7.20B7.30B6.30B5.19B
Cash Flow
Free Cash Flow353.00M622.00M766.00M152.00M510.00M
Operating Cash Flow1.12B1.26B1.50B915.00M1.11B
Investing Cash Flow-940.00M-1.35B-2.34B473.00M-458.00M
Financing Cash Flow-207.00M516.00M168.00M-652.00M-535.00M

Arkema Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price66.00
Price Trends
50DMA
62.36
Positive
100DMA
66.81
Negative
200DMA
70.25
Negative
Market Momentum
MACD
0.10
Negative
RSI
56.89
Neutral
STOCH
82.34
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:AKE, the sentiment is Neutral. The current price of 66 is above the 20-day moving average (MA) of 61.34, above the 50-day MA of 62.36, and below the 200-day MA of 70.25, indicating a neutral trend. The MACD of 0.10 indicates Negative momentum. The RSI at 56.89 is Neutral, neither overbought nor oversold. The STOCH value of 82.34 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:AKE.

Arkema Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
FRAKE
67
Neutral
€4.83B15.264.87%5.65%2.71%-10.61%
44
Neutral
C$967.20M-6.69-13.35%2.72%17.55%-32.18%
€101.44B30.6912.92%1.63%
€1.34B95.770.92%3.27%
€2.37B49.79-2.97%5.18%
€3.64B7.8919.37%8.20%
FRCBE
76
Outperform
€1.57B16.49
1.37%11.99%20.45%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:AKE
Arkema
66.00
-14.84
-18.35%
GB:0NWF
Air Liquide
175.88
13.68
8.43%
GB:0MGV
Eramet SA
48.78
-53.38
-52.25%
GB:0NPX
IMERYS SA
28.53
-4.36
-13.26%
GB:0NR2
Vallourec
16.49
3.12
23.34%
FR:CBE
Robertet SA Cert.d'Invest. Em.87
710.00
-44.52
-5.90%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 25, 2025